Guidance on applications for drug clinical trials under the interim order: Overview
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.
- Publisher
- Health Canada
- Resources
- 11
- Catalogue metadata updated
- 2021-05-28
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents (French, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Additional requirements (English, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Additional requirements (French, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Application guidelines and process (English, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: General requirements (French, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: General requirements (English, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Overview (English, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Overview (French, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements (English, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements (French, HTML) HTML
- Guidance on applications for drug clinical trials under the interim order: Who to contact (English, HTML) HTML